195 related articles for article (PubMed ID: 28608263)
1. Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study.
Real NE; Castro GN; Darío Cuello-Carrión F; Perinetti C; Röhrich H; Cayado-Gutiérrez N; Guerrero-Gimenez ME; Ciocca DR
Cell Stress Chaperones; 2017 Nov; 22(6):811-822. PubMed ID: 28608263
[TBL] [Abstract][Full Text] [Related]
2. Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.
Castro GN; Cayado-Gutiérrez N; Zoppino FC; Fanelli MA; Cuello-Carrión FD; Sottile M; Nadin SB; Ciocca DR
Cell Stress Chaperones; 2015 Mar; 20(2):253-65. PubMed ID: 25155585
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
[TBL] [Abstract][Full Text] [Related]
4. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
5. Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer.
Li S; Ren B; Shi Y; Gao H; Wang J; Xin Y; Huang B; Liao S; Yang Y; Xu Z; Li Y; Zeng Q
Exp Cell Res; 2019 Mar; 376(1):27-38. PubMed ID: 30690027
[TBL] [Abstract][Full Text] [Related]
6. Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients.
Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
Cancer Lett; 2007 Jul; 252(1):131-46. PubMed ID: 17276589
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer.
Xiao J; Zhou J; Liang L; Liu F; Liang H; Xu C; Meng J
J BUON; 2019; 24(3):967-974. PubMed ID: 31424649
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.
Nadin SB; Sottile ML; Montt-Guevara MM; Gauna GV; Daguerre P; Leuzzi M; Gago FE; Ibarra J; Cuello-Carrión FD; Ciocca DR; Vargas-Roig LM
Cell Stress Chaperones; 2014 Jul; 19(4):493-505. PubMed ID: 24307543
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.
Okuno M; Adachi S; Kozawa O; Shimizu M; Yasuda I
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805817
[TBL] [Abstract][Full Text] [Related]
12. DNA Damage Repair Proteins, HSP27, and Phosphorylated-HSP90α as Predictive/Prognostic Biomarkers of Platinum-based Cancer Chemotherapy: An Exploratory Study.
Sottile ML; Cuello-Carrión FD; Gómez LC; Semino S; Ibarra J; García MB; Gonzalez L; Vargas-Roig LM; Nadin SB
Appl Immunohistochem Mol Morphol; 2022 Jul; 30(6):425-434. PubMed ID: 35639358
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts.
Yunmbam MK; Guo Y; Miller MR; Yu JJ
Oncol Rep; 2004 Apr; 11(4):833-8. PubMed ID: 15010881
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Jiang Y; Song B; Chen Z
Comput Math Methods Med; 2022; 2022():5936773. PubMed ID: 35693259
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer.
Ercoli A; Ferrandina G; Genuardi M; Zannoni GF; Cicchillitti L; Raspaglio G; Carrara S; Mancuso S; Scambia G
Int J Gynecol Cancer; 2005; 15(2):308-11. PubMed ID: 15823117
[TBL] [Abstract][Full Text] [Related]
16. Curcumin causes DNA damage and affects associated protein expression in HeLa human cervical cancer cells.
Shang HS; Chang CH; Chou YR; Yeh MY; Au MK; Lu HF; Chu YL; Chou HM; Chou HC; Shih YL; Chung JG
Oncol Rep; 2016 Oct; 36(4):2207-15. PubMed ID: 27499229
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
18. Clusterin expression inversely correlates with chemosensitivity and predicts poor survival in patients with locally advanced cervical cancer treated with cisplatin-based neoadjuvant chemotherapy and radical hysterectomy.
Watari H; Kanuma T; Ohta Y; Hassan MK; Mitamura T; Hosaka M; Minegishi T; Sakuragi N
Pathol Oncol Res; 2010 Sep; 16(3):345-52. PubMed ID: 20058210
[TBL] [Abstract][Full Text] [Related]
19. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis.
Vici P; Di Benedetto A; Ercolani C; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Terrenato I; Dattilo R; Botti C; Fabi A; Ramieri MT; Mentuccia L; Marinelli C; Iezzi L; Gamucci T; Natoli C; Vitale I; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
Oncotarget; 2015 Dec; 6(40):42773-80. PubMed ID: 26544894
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
